Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Queen Elizabeth II Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT00336115
First received: June 9, 2006
Last updated: October 22, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: May 2008
  Estimated Primary Completion Date: No date given